Searched for
EQUITY RESEARCH ASSOCIATE
The accounting trick used by companies to make a weak balance sheet look strongIn one recent case, a large investment sat comfortably under equity until the auditor read the shareholders' agreement, found a buyback cla...12 Jun, 2026, 06.46 PM IST- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- Signs of worry: Is SpaceX's $75 billion IPO ringing the bell of market top?SpaceX's upcoming IPO at a staggering valuation is sparking debate. Investors wonder if this massive listing signals the peak of the curren...12 Jun, 2026, 10.22 AM IST
- Hidden AI India winners add $48 billion on data-center boomIndian industrial companies are experiencing significant growth by supplying components for data centers. This trend is driven by massive g...11 Jun, 2026, 02.40 PM IST
- Gold ETFs see first outflow in a year, silver ETFs bleed for fourth straight monthGold ETFs saw their first outflow in over a year in May, while silver ETFs extended losses for the fourth straight month, according to AMFI...10 Jun, 2026, 03.48 PM IST
- 5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...09 Jun, 2026, 01.55 PM IST
- Change drivers : creating industry-wide impactThis article highlights individuals driving innovation and trust in various sectors. Shiva Sankeerth Reddy Yarradla is revolutionizing ente...08 Jun, 2026, 02.18 PM IST
- RBI widens direct equity access for overseas investors, doubles investment limits under PISThe RBI has doubled investment limits for overseas individual investors under the Portfolio Investment Scheme and extended direct equity ac...08 Jun, 2026, 12.12 PM IST
- ED's Parimatch heat reaches Zepto; SPC's India deeptech pushZepto has come under the ED's scanner as part of its probe into Parimatch. This and more in today's ETtech Top 5.05 Jun, 2026, 07.33 PM IST
- Trump shifts higher education fight from campus probes to federal rulebookThe Trump administration is changing its approach to higher education. Instead of targeting individual campuses, new federal rules are bein...04 Jun, 2026, 05.02 PM IST
- The great $100-billion tech shift: GCCs tighten grip on India’s talent marketIndia's Global Capability Centres (GCCs) jobs: India's Global Capability Centres (GCCs) are rapidly outpacing traditional IT services, driv...04 Jun, 2026, 10.54 AM IST
- India's tougher grid rules unsettle investors, test clean energy ambitionsIndia's new power grid rules are causing concern among clean energy investors, who say stricter penalties for solar and wind projects would...04 Jun, 2026, 09.50 AM IST
- Nvidia salary shock: Engineers earn up to Rs 4.7 crore as AI boom creates millionaire employees; check salary structureNvidia is aggressively competing for AI talent, with top engineering roles now offering base salaries up to ₹4.7 crore. This significant co...02 Jun, 2026, 11.45 AM IST
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...01 Jun, 2026, 11.51 AM IST
- NSE pre-IPO window to close soon with filing weeks away. Can buying unlisted shares now make you good money?PSU banks achieved historic profit and NPA lows in FY26, yet analysts favor leading private banks for FY27. This shift is driven by superio...01 Jun, 2026, 09.59 AM IST
- Corporate India posts 25% profit surge in Q4 FY26, but rising costs squeeze marginsCorporate India's March quarter net profit surged 25.3%, driven by non-operating factors, masking operating challenges like rising input co...01 Jun, 2026, 06.00 AM IST
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...30 May, 2026, 10.35 AM IST
Load More
